Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Biological Therapy Analysis & Statistics, October 2012 (p8)

You might be interested in: stem cell, cell therapy, tissue engineering, more »

» Purchase Premium Reports

211-240 of about 400 reports
Primary Systemic Amyloidosis - Pipeline Review, H2 2012

Primary Systemic Amyloidosis - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • October 2012
  • by Global Markets Direct

Primary Systemic Amyloidosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic ...

  • Industries : Biological Therapy
  • Countries : World
Antisense Pharma GmbH - Product Pipeline Review - 2012

Antisense Pharma GmbH - Product Pipeline Review - 2012

  • $ 1 500
  • Company report
  • October 2012
  • by Global Markets Direct

Antisense Pharma GmbH - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Antisense Therapeutics Limited - Product Pipeline Review - 2012? provides data on the Antisense ...

  • Industries : Biological Therapy
  • Countries : World
Mesoblast Limited - Product Pipeline Review - 2012

Mesoblast Limited - Product Pipeline Review - 2012

  • $ 1 500
  • Company report
  • October 2012
  • by Global Markets Direct

Mesoblast Limited - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Mesoblast Limited - Product Pipeline Review - 2012? provides data on the Mesoblast Limited's ...

  • Industries : Biological Therapy
  • Countries : India, United States, World
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)

  • $ 4 650
  • Industry report
  • October 2012
  • by MarketsandMarkets

Autologous cell therapies are new therapeutic intervention where it introduces or uses cells or tissues from the individual, cultured, expanded and re-introduced at the site of the disease of the donor. ...

  • Industries : Biological Therapy
  • Countries : United States
Oxford BioTherapeutics Ltd - Medical Equipment - Deals and Alliances Profile

Oxford BioTherapeutics Ltd - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2012
  • by Global Data

Oxford BioTherapeutics Ltd - Medical Equipment - Deals and Alliances Profile Summary Oxford BioTherapeutics Ltd (Oxford BioTherapeutics) is a biopharmaceutical company, based in the UK. The company develops ...

  • Industries : Biological Therapy
Amyloidosis - Pipeline Review, H2 2012

Amyloidosis - Pipeline Review, H2 2012

  • $ 2 000
  • Industry report
  • September 2012
  • by Global Markets Direct

Amyloidosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Biological Therapy
  • Countries : World
Market and Product Forecasts: Top 20 Oncology Therapy Brands 2011-21 - Avastin fails to top any individual market in 2011

Market and Product Forecasts: Top 20 Oncology Therapy Brands 2011-21 - Avastin fails to top any individual market in 2011

  • $ 11 400
  • Industry report
  • September 2012
  • by Datamonitor

The high level of commercial success experienced by the key companies in the cancer therapy market makes the market extremely attractive to drug developers. Treatment of cancer has shifted toward a more ...

  • Industries : Biological Therapy
  • Countries : Japan
Other Immunological Disorders - Pipeline Review, H2 2012

Other Immunological Disorders - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • August 2012
  • by Global Markets Direct

Other Immunological Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Other Immunological Disorders - Pipeline Review, H2 2012', provides an overview of the Other Immunological Disorders ...

  • Industries : Biological Therapy
  • Countries : World, Australia
Product Profiles: Targeted Cancer Therapies - Patient selection driving novel drug approvals

Product Profiles: Targeted Cancer Therapies - Patient selection driving novel drug approvals

  • $ 11 400
  • Industry report
  • August 2012
  • by Datamonitor

The rising incidence of cancer is continuing to drive intense R&D interest in oncology. Drug developers are shifting their attention towards the development of novel therapies for molecularly defined patient ...

  • Industries : Biological Therapy
  • Countries : United States
Genitope Corporation (GTOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genitope Corporation (GTOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2012
  • by Global Data

Genitope Corporation (GTOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Genitope Corporation (Genitope) is a publicly held US based biotechnology company. It is focused on the ...

  • Industries : Biological Therapy
  • Countries : United States
Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

  • $ 2 795
  • Industry report
  • August 2012
  • by Transparency Market Research

Circulating tumor cell technology is an enabling technology for recovery and analysis of separated cancer cells in the peripheral blood. CTC technology offers advantages like high sensitivity, high specificity, ...

  • Industries : Biological Therapy
  • Countries : World
Emerging Pharmaceutical Technologies - Stem cells

Emerging Pharmaceutical Technologies - Stem cells

  • $ 3 900
  • Industry report
  • August 2012
  • by CBR Pharma Insights

Stem cell technology is set to play a significant role in the pharmaceutical industry of the future. The opportunities for using stem cells across drug discovery, disease research, drug development and ...

  • Industries : Biological Therapy
TiGenix NV (TIG) - Product Pipeline Analysis

TiGenix NV (TIG) - Product Pipeline Analysis

  • $ 750
  • Company report
  • August 2012
  • by Global Data

TiGenix NV (TIG) - Product Pipeline Analysis Summary TiGenix NV (TiGenix) is a publicly held biomedical cell therapy company. The company carries out the development of innovative local treatments fo ...

  • Industries : Biological Therapy
  • Countries : Finland, Belgium
Biological Therapy: Bioheart, Inc. (BHRT)

Biological Therapy: Bioheart, Inc. (BHRT)

  • $ 750
  • Company report
  • August 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Bioheart, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Biological Therapy
  • Countries : United States
Merger & Acquisition in Medical Equipment Industry: International Stem Cell Corporation (ISCO)

Merger & Acquisition in Medical Equipment Industry: International Stem Cell Corporation (ISCO)

  • $ 250
  • Company report
  • August 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
World Biological Therapy: Brachytherapy Devices

World Biological Therapy: Brachytherapy Devices

  • $ 3 995
  • Industry report
  • August 2012
  • by Global Data

The report provides global industry value (USD million) for the two industry categories - permanent brachytherapy devices and temporary brachytherapy devices. The report is a key source for the current ...

  • Industries : Biological Therapy
  • Countries : World
Natural Killer Cell Lymphomas - Pipeline Review, H2 2012

Natural Killer Cell Lymphomas - Pipeline Review, H2 2012

  • $ 500
  • Company report
  • July 2012
  • by Global Markets Direct

Natural Killer Cell Lymphomas - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Natural Killer Cell Lymphomas - Pipeline Review, H2 2012', provides an overview of the Natural Killer Cell ...

  • Industries : Biological Therapy
  • Countries : United States, World
Market and Product Forecasts: Targeted Cancer Therapies 2011-21 -  Eurozone price cuts impact targeted cancer therapies market

Market and Product Forecasts: Targeted Cancer Therapies 2011-21 - Eurozone price cuts impact targeted cancer therapies market

  • $ 11 400
  • Industry report
  • July 2012
  • by Datamonitor

The targeted therapies class has fueled most of the recent rapid growth of the oncology market as a whole. In the next decade the market will become more fragmented as new targeted therapies are developed ...

  • Industries : Biological Therapy
  • Countries : Europe, United States, Japan, Spain, Italy, France, Germany, World, United Kingdom
Global Markets for Stem Cells

Global Markets for Stem Cells

  • $ 6 650
  • Industry report
  • July 2012
  • by BCC Research

INTRODUCTION STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription drug products. ...

  • Industries : Biological Therapy
  • Countries : World
Zhongyuan Union Stem Cell Bioengineering Co., Ltd. (600645) - Company Capsule

Zhongyuan Union Stem Cell Bioengineering Co., Ltd. (600645) - Company Capsule

  • $ 75
  • Company report
  • July 2012
  • by World Market Intelligence Ltd

Synopsis WMI's 'Zhongyuan Union Stem Cell Bioengineering Co., Ltd. (600645) - Company Capsule' contains a company overview, key facts, key employees, products and services, key competitors as well as financial ...

  • Industries : Biological Therapy
Global Human Embryonic Stem Cell (hESC) Research Industry

Global Human Embryonic Stem Cell (hESC) Research Industry

  • $ 3 450
  • Industry report
  • July 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Human Embryonic Stem Cell (hESC) Research in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual ...

  • Industries : Biological Therapy
  • Countries : United States, World
Survey: 7 Things You Need to Know to Profit from Feeder-Free Culture

Survey: 7 Things You Need to Know to Profit from Feeder-Free Culture

  • $ 177
  • Industry report
  • July 2012
  • by BioInformant Worldwide, L.L.C.

Following a series of requests from our clients to explore the topic of feeder-dependent versus feeder-free culture using our Scientist Panel, we completed a survey on this topic. The key findings are ...

  • Industries : Biological Therapy
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) ...

  • Industries : Biological Therapy
  • Countries : World, United States
Alpha-Mannosidosis - Pipeline Review, H1 2012

Alpha-Mannosidosis - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Alpha-Mannosidosis - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Alpha-Mannosidosis - Pipeline Review, H1 2012', provides an overview of the Alpha-Mannosidosis therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards Summary GBI Research's new report, ?Gene Therapy Market to ...

  • Industries : Biological Therapy
  • Countries : World
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications Summary GBI Research, the leading business intelligence ...

  • Industries : Biological Therapy
  • Countries : World
Competitor Analysis: Immunotherapy of Alzheimer`s Disease

Competitor Analysis: Immunotherapy of Alzheimer`s Disease

  • $ 528
  • Industry report
  • May 2012
  • by La Merie Publishing

Competitor Analysis: Immunotherapy of Alzheimer's Disease The Competitive Intelligence Report Immunotherapy of Alzheimer's Disease as of May 2012 provides a competitor analysis in the development pipeline ...

  • Industries : Biological Therapy
ProStrakan Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

ProStrakan Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2012
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Global Stem Cell Research Industry

Global Stem Cell Research Industry

  • $ 4 500
  • Industry report
  • May 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Stem Cell Research in US$ Million. Annual estimates and forecasts are provided for the period 2008 through 2017. The report provides separate comprehensive ...

  • Industries : Biological Therapy
  • Countries : World, United States
Fibrocell Sciences, Inc. (Symbol:ILEIQ) SWOT Analysis, Strategy, Revenues and Profits

Fibrocell Sciences, Inc. (Symbol:ILEIQ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States

» View Public Reports

About 900 reports

Cell Culture Business (cell culture, cell therapy) in Thailand and The United States

  • Industry report
  • March 2014
  • 7 pages
  • by Research Paper

... cultured cells selected for high production of secondary metabolites (dicosmo and misawa, 1995). One way to increase the production level of secondary metabolites is by elicitation, which ...


» Read our Company Profiles

35 Companies

GlaxoSmithKline P.L.C.

United States

Bioheart Inc.

United States

StemCells Inc.

United States

Geron Corp.

United States

Osiris Therapeutics Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.